Singapore markets open in 4 hours 47 minutes
Straits Times Index
3,147.39 -44.96 (-1.41%) S&P 500
4,263.75 +34.30 (+0.81%) Dow
33,129.55 +127.17 (+0.39%) Nasdaq
13,236.01 +176.54 (+1.35%) Bitcoin USD
27,660.79 +351.50 (+1.29%) CMC Crypto 200
588.52 +4.36 (+0.75%)
Fortress Biotech Inc (CNB.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
At close: 09:52PM CEST
| Previous close | 0.2980 |
| Open | 0.2960 |
| Bid | 0.2560 x 0 |
| Ask | 0.3380 x 0 |
| Day's range | 0.2960 - 0.3040 |
| 52-week range | 0.2660 - 1.0465 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 13 Nov 2023 - 17 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksFortress Biotech (FBIO) Reports Q1 Loss, Lags Revenue Estimates
Fortress Biotech (FBIO) delivered earnings and revenue surprises of -10.53% and 23.98%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksEarnings Preview: Fortress Biotech (FBIO) Q1 Earnings Expected to Decline
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksFortress Biotech (FBIO) Reports Q3 Loss, Misses Revenue Estimates
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 7.41% and 13.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
